BioAtla (BCAB) Current Assets (2020 - 2026)
BioAtla (BCAB) posted quarterly Current Assets of $3.1 million for Q1 2026, down 91.76% year-over-year from $37.5 million in Q1 2025, and down 61.4% quarter-over-quarter from $8.0 million in Q4 2025.
BioAtla (BCAB) Current Assets (2020 - 2026) Analysis & Trends
BioAtla's Current Assets history runs 7 years deep, the most recent figure standing at $3.1 million for Q1 2026.
- In Q1 2026, Current Assets fell 91.76% year-over-year to $3.1 million; the TTM figure through Mar 2026 stood at $3.1 million (down 91.76% YoY), while the FY2025 annual figure was $8.0 million, down 84.36% from the prior year.
- Current Assets for Q1 2026 stood at $3.1 million, down from $8.0 million in the prior quarter.
- The five-year high for Current Assets was $224.0 million in Q1 2022, with the low at $3.1 million in Q1 2026.
- The 5-year median for Current Assets is $86.4 million (2024), against an average of $106.9 million.
- The sharpest annual moves came in 2022 and 2026: Current Assets dropped 0.25% in 2022, then slumped 91.76% in 2026.
- BioAtla's Current Assets stood at $220.4 million in 2022, then sank by 47.19% to $116.4 million in 2023, then slumped by 55.99% to $51.2 million in 2024, then plunged by 84.36% to $8.0 million in 2025, then slumped by 61.4% to $3.1 million in 2026.
- Business Quant data shows BCAB's Current Assets at $3.1 million in Q1 2026, $8.0 million in Q4 2025, and $9.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 4.62 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 1.63 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 1.76 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 18.80 Bn |
| 10 | BioAtla | 5.28 Mn | 5.28 Mn | - | 4.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 4.26 Mn |
| Mar 31, 2026 | 3.09 Mn |
| Dec 31, 2025 | 8.01 Mn |
| Sep 30, 2025 | 9.67 Mn |
| Jun 30, 2025 | 20.61 Mn |
| Mar 31, 2025 | 37.54 Mn |
| Dec 31, 2024 | 51.23 Mn |
| Sep 30, 2024 | 60.57 Mn |
| Jun 30, 2024 | 66.49 Mn |
| Mar 31, 2024 | 86.43 Mn |
| Dec 31, 2023 | 116.41 Mn |
| Sep 30, 2023 | 147.51 Mn |
| Jun 30, 2023 | 175.31 Mn |
| Mar 31, 2023 | 199.72 Mn |
| Dec 31, 2022 | 220.43 Mn |
| Sep 30, 2022 | 183.31 Mn |
| Jun 30, 2022 | 207.20 Mn |
| Mar 31, 2022 | 224.02 Mn |
| Dec 31, 2021 | 247.29 Mn |
| Sep 30, 2021 | 273.52 Mn |